Logo image of RSLS

RESHAPE LIFESCIENCES INC (RSLS) Stock Overview

NASDAQ:RSLS - US76090R3093 - Common Stock

3.92 USD
+0.72 (+22.5%)
Last: 8/14/2025, 8:00:01 PM
3.22 USD
-0.7 (-17.86%)
After Hours: 8/14/2025, 8:00:01 PM

RSLS Key Statistics, Chart & Performance

Key Statistics
52 Week High303.25
52 Week Low1.87
Market Cap81.26M
Shares20.73M
Float2.13M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-212.11
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO10-06 2016-10-06
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


RSLS short term performance overview.The bars show the price performance of RSLS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 -50

RSLS long term performance overview.The bars show the price performance of RSLS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of RSLS is 3.92 USD. In the past month the price increased by 37.54%. In the past year, price decreased by -98.49%.

RESHAPE LIFESCIENCES INC / RSLS Daily stock chart

RSLS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.06 230.77B
ISRG INTUITIVE SURGICAL INC 59.15 170.69B
BSX BOSTON SCIENTIFIC CORP 37.52 157.32B
SYK STRYKER CORP 30.68 150.71B
MDT MEDTRONIC PLC 16.76 118.79B
BDX BECTON DICKINSON AND CO 13.99 57.23B
IDXX IDEXX LABORATORIES INC 53.75 51.64B
EW EDWARDS LIFESCIENCES CORP 31.84 48.04B
RMD RESMED INC 30.76 43.01B
GEHC GE HEALTHCARE TECHNOLOGY 16.14 34.34B
DXCM DEXCOM INC 48.39 32.26B
PHG KONINKLIJKE PHILIPS NVR- NY 16.97 27.29B

About RSLS

Company Profile

RSLS logo image ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 17 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Company Info

RESHAPE LIFESCIENCES INC

1001 Calle Amanecer

San Clemente CALIFORNIA 92673 US

CEO: Andrew Rasdal

Employees: 17

RSLS Company Website

RSLS Investor Relations

Phone: 19494296680

RESHAPE LIFESCIENCES INC / RSLS FAQ

What is the stock price of RESHAPE LIFESCIENCES INC today?

The current stock price of RSLS is 3.92 USD. The price increased by 22.5% in the last trading session.


What is the ticker symbol for RESHAPE LIFESCIENCES INC stock?

The exchange symbol of RESHAPE LIFESCIENCES INC is RSLS and it is listed on the Nasdaq exchange.


On which exchange is RSLS stock listed?

RSLS stock is listed on the Nasdaq exchange.


What is RESHAPE LIFESCIENCES INC worth?

RESHAPE LIFESCIENCES INC (RSLS) has a market capitalization of 81.26M USD. This makes RSLS a Micro Cap stock.


How many employees does RESHAPE LIFESCIENCES INC have?

RESHAPE LIFESCIENCES INC (RSLS) currently has 17 employees.


Is RESHAPE LIFESCIENCES INC (RSLS) expected to grow?

The Revenue of RESHAPE LIFESCIENCES INC (RSLS) is expected to grow by 20% in the next year. Check the estimates tab for more information on the RSLS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy RESHAPE LIFESCIENCES INC (RSLS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RESHAPE LIFESCIENCES INC (RSLS) stock pay dividends?

RSLS does not pay a dividend.


When does RESHAPE LIFESCIENCES INC (RSLS) report earnings?

RESHAPE LIFESCIENCES INC (RSLS) will report earnings on 2025-11-12.


What is the Price/Earnings (PE) ratio of RESHAPE LIFESCIENCES INC (RSLS)?

RESHAPE LIFESCIENCES INC (RSLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-212.11).


RSLS Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to RSLS. When comparing the yearly performance of all stocks, RSLS is a bad performer in the overall market: 99.02% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

RSLS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RSLS. While RSLS seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RSLS Financial Highlights

Over the last trailing twelve months RSLS reported a non-GAAP Earnings per Share(EPS) of -212.11. The EPS increased by 93.64% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -53.42%
ROE -281.54%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%114%
Sales Q2Q%-42.75%
EPS 1Y (TTM)93.64%
Revenue 1Y (TTM)-13.93%

RSLS Forecast & Estimates

For the next year, analysts expect an EPS growth of 20% and a revenue growth 20% for RSLS


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y20%
Revenue Next Year20%

RSLS Ownership

Ownership
Inst Owners0.73%
Ins Owners0.06%
Short Float %N/A
Short Ratio0.06